Novel biomarkers for the diagnosis and prognosis of gallbladder cancer
- PMID: 33369216
- DOI: 10.1111/1751-2980.12966
Novel biomarkers for the diagnosis and prognosis of gallbladder cancer
Abstract
Gallbladder cancer (GBC) is the most common form of biliary tract malignancy with a dismal prognosis. A poor outcome in patients with GBC is related to the aggressive nature of the tumor, delayed diagnosis, and a lack of reliable biomarkers and effective treatment. Therefore, early diagnosis and accurate disease assessment are crucial to prolonging the patient survival. Identification of novel prognostic and diagnostic biomarkers may help improve the early diagnostic rate and develop specific targeted treatments for patients with GBC. We herein review the novel biomarkers that may be associated with the diagnosis and prognosis in GBC and their potential clinical significance in the management of GBC.
Keywords: diagnosis; gallbladder neoplasms; novel biomarker; prognosis.
© 2020 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.
Similar articles
-
Molecular pathways and potential biomarkers in gallbladder cancer: A comprehensive review.Surg Oncol. 2019 Dec;31:83-89. doi: 10.1016/j.suronc.2019.09.006. Epub 2019 Sep 13. Surg Oncol. 2019. PMID: 31541911 Review.
-
Molecular pathogenesis of gallbladder cancer: An update.Mutat Res. 2019 Nov;816-818:111674. doi: 10.1016/j.mrfmmm.2019.111674. Epub 2019 Jul 6. Mutat Res. 2019. PMID: 31330366 Review.
-
MicroRNA aberrations: An emerging field for gallbladder cancer management.World J Gastroenterol. 2016 Feb 7;22(5):1787-99. doi: 10.3748/wjg.v22.i5.1787. World J Gastroenterol. 2016. PMID: 26855538 Free PMC article. Review.
-
Role of stratifin (14-3-3 sigma) in adenocarcinoma of gallbladder: A novel prognostic biomarker.Surg Oncol. 2020 Mar;32:57-62. doi: 10.1016/j.suronc.2019.10.022. Epub 2019 Nov 2. Surg Oncol. 2020. PMID: 31751820
-
Circular RNA circ-MTO1 serves as a novel potential diagnostic and prognostic biomarker for gallbladder cancer.Eur Rev Med Pharmacol Sci. 2020 Aug;24(16):8359-8366. doi: 10.26355/eurrev_202008_22632. Eur Rev Med Pharmacol Sci. 2020. PMID: 32894542
Cited by
-
A Systematic Review and Meta-Analysis: Volatile Organic Compound Analysis in the Detection of Hepatobiliary and Pancreatic Cancers.Cancers (Basel). 2023 Apr 14;15(8):2308. doi: 10.3390/cancers15082308. Cancers (Basel). 2023. PMID: 37190235 Free PMC article. Review.
-
Computational Tactics for Precision Cancer Network Biology.Int J Mol Sci. 2022 Nov 19;23(22):14398. doi: 10.3390/ijms232214398. Int J Mol Sci. 2022. PMID: 36430875 Free PMC article. Review.
-
Reiterating the Emergence of Noncoding RNAs as Regulators of the Critical Hallmarks of Gall Bladder Cancer.Biomolecules. 2021 Dec 8;11(12):1847. doi: 10.3390/biom11121847. Biomolecules. 2021. PMID: 34944491 Free PMC article. Review.
-
Quantitative detections of TP53 gene mutations improve the diagnosis and prognostic prediction of biliary tract cancers using droplet digital PCR.J Clin Lab Anal. 2022 Jan;36(1):e24103. doi: 10.1002/jcla.24103. Epub 2021 Nov 23. J Clin Lab Anal. 2022. PMID: 34813121 Free PMC article.
References
REFERENCES
-
- Bridgewater JA, Goodman KA, Kalyan A, Mulcahy MF. Biliary tract cancer: epidemiology, radiotherapy, and molecular profiling. Am Soc Clin Oncol Educ Book. 2016;35:e194-e203. https://doi.org/10.1200/EDBK_160831.
-
- Van Dyke AL, Shiels MS, Jones GS, et al. Biliary tract cancer incidence and trends in the United States by demographic group, 1999-2013. Cancer. 2019;125(9):1489-1498.
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7-34.
-
- Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 2014;6:99-109.
-
- Singh SK, Talwar R, Kannan N, Tyagi AK, Jaiswal P, Kumar A. Chemotherapy compared with best supportive care for metastatic/unresectable gallbladder cancer: a non-randomized prospective cohort study. Indian J Surg Oncol. 2016;7(1):25-31.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical